68.
69.
Klotz U. Tramadol – the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain. Arzneim Forsch Drug Res. 2003;53(10):681–7.
70.
71.
72.
Picard N, Cresteil T, Djebli N, Marquet P. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways. Drug Metab Dispos. 2005;33:689–95.PubMedCrossRef